Mortalin controls centrosome duplication via modulating centrosomal localization of p53

Oncogene

Volumn 25, Issue 39, 2006, Pages 5377-5390

  Ma, Z ^a   Izumi, H ^a   Kanai, M ^a   Kabuyama, Y ^b   Ahn, N G ^b   Fukasawa, K ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Centrosome; Centrosome duplication; Mortalin; p53

Indexed keywords

DNA; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; PROTEIN MORTALIN; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CENTROSOME; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; GENE DUPLICATION; HELA CELL; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MITOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION;

CELL CYCLE; CENTROSOME; CLONE CELLS; G1 PHASE; G2 PHASE; GENES, P53; HELA CELLS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MITOSIS; S PHASE; TRANSCRIPTION, GENETIC;

EID: 33748286872     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209543     Document Type: Article

References (31)

1. Agarwal ML, Agarwal A, Taylor WR, Stark GR. (1995). Proc Natl Acad Sci USA 92: 8493-8497.
2. Blair Zajdel ME, Blair GE. (1988). Oncogene 2: 579-584.
3. Brown CR, Doxsey SJ, White E, Welch WJ. (1994). J Cell Physiol 160: 47-60.
4. Brummelkamp TR, Bernards R, Agami R. (2002). Science 296: 550-553.
5. Ciciarello M, Mangiacasale R, Casenghi M, Zaira Limongi M, D'Angelo M, Soddu S et al. (2001). J Biol Chem 276: 19205-19213.
6. Crook T, Marston NJ, Sara EA, Vousden KH. (1994). Cell 79: 817-827.
7. D'Assoro AB, Lingle WL, Salisbury JL. (2002). Oncogene 40: 6146-6153.
8. Fukasawa K. (2005). Cancer Lett 230: 6-19.
9. Hadari YR, Haring HU, Zick Y. (1997). J Biol Chem 272: 657-662.
10. Hinchcliffe EH, Sluder G. (2002). Oncogene 21: 6154-6160.
11. Hollstein M, Sidransky D, Vogelstein B, Harris CC. (1991). Science 253: 49-53.
12. Kaul SC, Reddel RR, Mitsui Y, Wadhwa R. (2001). Neoplasia 3: 110-114.
13. Kaul SC, Taira K, Pereira-Smith OM, Wadhwa R. (2002). Exp Gerontol 37: 1157-1164.
14. Kawamura K, Izumi H, Ma Z, Ikeda R, Moriyama M, Tanaka T et al. (2004). Cancer Res 64: 4800-4809.
15. Lange BM, Gull K. (1996). Trends Cell Biol 6: 348-352.
16. Morris VB, Brammall J, Noble J, Reddel R. (2000). Exp Cell Res 256: 122-130.
17. Mussman JG, Horn HF, Carroll PE, Okuda M, Tarapore P, Donehower LA et al. (2000). Oncogene 19: 1635-1646.
18. Oakley BR. (2000). Curr Top Dev Biol 49: 27-54.
19. Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK et al. (2000). Cell 103: 127-140.
20. Ran Q, Wadhwa R, Kawai R, Kaul SC, Sifers RN, Bick RJ et al. (2000). Biochem Biophys Res Commun 275: 174-179.
21. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. (1990). Cell 63: 1129-1136.
22. Stewart N, Hicks GG, Paraskevas F, Mowat M. (1995). Oncogene 10: 109-115.
23. Tarapore P, Fukasawa K. (2002). Oncogene 21: 6234-6240.
24. Tarapore P, Horn HF, Tokuyama Y, Fukasawa K. (2001a). Oncogene 20: 3173-3184.
25. Tarapore P, Tokuyama Y, Horn HF, Fukasawa K. (2001b). Oncogene 20: 6851-6863.
26. Timson J. (1975). Mutat Res 32: 115-132.
27. Tsujimoto Y. (1998). Genes Cells 3: 697-707.
28. Wadhwa R, Kaul SC, Mitsui Y, Sugimoto Y. (1993). Exp Cell Res 207: 442-448.
29. Wadhwa R, Pereira-Smith OM, Reddel RR, Sugimoto Y, Mitsui Y, Kaul SC. (1995). Exp Cell Res 216: 101-106.
30. Wadhwa R, Takano S, Robert M, Yoshida A, Nomura H, Reddel RR et al. (1998). J Biol Chem 273: 29586-29591.
31. Wadhwa R, Yaguchi T, Hasan MK, Mitsui Y, Reddel RR, Kaul SC. (2002). Exp Cell Res 274: 246-253.